Y Oyama Selected Research

tranilast

1/2022

Tranilast, an antifibrotic agent and COVID-19-induced pulmonary fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Y Oyama Research Topics

Disease

4	Autoimmune Diseases (Autoimmune Disease) 03/2007 - 08/2003
3	Systemic Scleroderma (Systemic Sclerosis) 09/2007 - 03/2007
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2007 - 08/2003
2	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2007 - 10/2001
2	Crohn Disease (Crohn's Disease) 03/2007 - 08/2003
2	Multiple Sclerosis 09/2006 - 01/2002
2	Rheumatoid Arthritis 10/2001 - 10/2001
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Chronic Limb-Threatening Ischemia 01/2010
1	Proteinuria 07/2009
1	Nephritis 07/2009
1	Glomerulonephritis 07/2009
1	Glucose Intolerance 03/2009
1	Myotonic Dystrophy (Dystrophia Myotonica) 03/2009
1	Behcet Syndrome (Behcet's Syndrome) 07/2008
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 07/2008
1	Systemic Vasculitis 07/2008
1	Cardiotoxicity 07/2007
1	Relapsing-Remitting Multiple Sclerosis 03/2007
1	Chronic Progressive Multiple Sclerosis 03/2007
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 09/2006
1	Pemphigus (Pemphigus Vulgaris) 12/2004
1	Fabry Disease (Fabry's Disease) 03/2004
1	Diarrhea 08/2003
1	Abdominal Pain (Pain, Abdominal) 08/2003
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 08/2003
1	Body Weight (Weight, Body) 05/2003
1	Exanthema (Rash) 01/2002
1	Fever (Fevers) 01/2002
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2001
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 11/2001
1	Evans Syndrome 11/2001
1	Aplastic Anemia (Anemia, Hypoplastic) 10/2001
1	Disease Progression 10/2001
1	Anemia 03/2000
1	Nephrotic Syndrome (Syndrome, Nephrotic) 03/2000
1	Lymphoma (Lymphomas) 03/2000
1	Leukemia 01/2000
1	Atherosclerotic Plaque (Atheroma) 01/2000

Drug/Important Bio-Agent (IBA)

2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2007 - 09/2006
1	tranilastIBA 01/2022
1	SteroidsIBA 07/2009
1	Cytotoxins (Cytolysins)IBA 07/2009
1	Immunoglobulin G (IgG)IBA 07/2009
1	P-2 (P 2)IBA 03/2009
1	HLA Antigens (Human Leukocyte Antigens)IBA 07/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2007
1	Stem Cell FactorIBA 09/2006
1	Thrombopoietin (c-mpl Ligand)IBA 09/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2006
1	flt3 ligand protein (flt3 ligand)IBA 09/2006
1	alpha-Galactosidase (Beano)IBA 03/2004
1	Nonsense Codon (Nonsense Mutation)IBA 03/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2003
1	Inosine Triphosphate (ITP)IBA 11/2001
1	Pharmaceutical PreparationsIBA 10/2001
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 03/2000
1	Immunoglobulin M (IgM)IBA 03/2000
1	Immunoglobulins (Immunoglobulin)IBA 03/2000
1	LigandsIBA 01/2000
1	PPAR gammaIBA 01/2000
1	OsteopontinIBA 01/2000
1	Troglitazone (Rezulin)FDA Link 01/2000
1	Phorbol EstersIBA 01/2000

Therapy/Procedure

14	Hematopoietic Stem Cell Transplantation 09/2007 - 10/2001
7	Therapeutics 07/2008 - 10/2001
4	Stem Cell Transplantation 07/2008 - 10/2001
2	Drug Therapy (Chemotherapy) 07/2008 - 03/2000
1	Limb Salvage 01/2010
1	Surgical Amputation (Amputations) 01/2010
1	Remission Induction 07/2008
1	Secondary Prevention 07/2008
1	Transplantation 08/2003